ArticleMultiple sclerosis journal - experimental, translational and clinical
Prevalence and incidence of multiple sclerosis in Kosovo: Data from Kosovan national multiple sclerosis registry.
Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Many studies report different prevalence and incidence estimates for multiple sclerosis (MS). Epidemiological data from Southeast Europe remain scarce. Objectives: This study aimed to estimate the prevalence, incidence, and demographic characteristics of MS in the Republic of Kosovo using data from the National MS Registry. Methods: The Kosovo National MS Registry was established in January 2020. Patients diagnosed according to the 2017 McDonald criteria are automatically registered. Demographic and epidemiological data of all registered patients up to December 31, 2025, were analyzed. Prevalence and incidence rates were calculated using population data from the 2024 national census. Results: A total of 776 MS patients were registered. Females accounted for 64.1% ( Conclusion: The results indicate a moderate prevalence with a steadily rising incidence, although the actual prevalence may be higher due to incomplete historical data prior to the registry's establishment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.